Stacy M Townsend Selected Research

Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)

1/2022	Polycationic Glycopolymer Demonstrates Activity Against Persisters and Biofilms of Non-tuberculosis Mycobacteria Cystic Fibrosis Clinical Isolates in vitro.
1/2018	In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus.
1/2018	Novel Glycopolymer Eradicates Antibiotic- and CCCP-Induced Persister Cells in Pseudomonas aeruginosa.
1/2017	Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stacy M Townsend Research Topics

Disease

5	Infections 01/2022 - 12/2006
1	Dehydration (Water Stress) 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Pseudomonas Infections 01/2018
1	Persistent Infection 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2017
1	Brain Abscess (Abscess, Brain) 12/2006

Drug/Important Bio-Agent (IBA)

4	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 01/2022 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2017
2	Tobramycin (Nebcin)FDA LinkGeneric 01/2018 - 01/2017
1	Glucosamine (Dona)IBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 01/2019
1	MucinsIBA 01/2019
1	arginyl)glucosamine poly-N (acetylIBA 01/2018
1	Aztreonam FDA LinkGeneric 01/2018
1	Colistin (Coly-Mycin)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2018
1	Meropenem (Merrem)FDA LinkGeneric 01/2017
1	Interleukin-12 (IL 12)IBA 12/2006
1	InterleukinsIBA 12/2006
1	CytokinesIBA 12/2006

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2017
1	Contraindications 01/2017